Doença de Alzheimer: é possível prevenir?
DOI:
https://doi.org/10.34119/bjhrv7n2-157Keywords:
doença de Alzheimer, demência, prevenção, qualidade de vidaAbstract
Milhões de pessoas sofrem com a Doença de Alzheimer e ainda não há um tratamento-padrão que consiga parar ou reverter a descendente espiral da doença. Este estudo objetivou, com uma revisão narrativa da literatura, conhecer as práticas que vêm sendo utilizadas na prevenção da Doença de Alzheimer entendendo como estas práticas melhoram a qualidade de vida e fornecem opções para uma longevidade mais saudável. Para a busca dos artigos da presente revisão, foi utilizada a base de dados Medline, por meio do PubMed. Os resultados da pesquisa permitiram identificar compostos, como vitaminas D e B12, curcumina, ácido α-lipoico, flavonoides e quercetina, retardando a progressão da Doença de Alzheimer, revertendo alterações inflamatórias no hipocampo, atenuando acúmulo de beta-amiloide ou modulando a resposta imune e se mostrando capazes de melhorar a aprendizagem, a memória e as funções cognitivas em pacientes com Doença de Alzheimer. Diversos estudos demonstram a importância do exercício físico e do sono para o sistema nervoso central e a associação entre distúrbios do sono e distúrbios neurodegenerativos como Doença de Alzheimer, e outros destacam a importância do controle da doença periodontal e dos níveis de açúcar no corpo para a prevenção da Doença de Alzheimer. Com a pesquisa realizada pode-se observar a importância da adoção de estilos de vida saudáveis, da higiene do sono e da boa saúde bucal e intestinal para manter a saúde do cérebro e as faculdades mentais, indicando que pequenas mudanças nos hábitos de cada indivíduo podem impactar o seu futuro.
References
AGHJAYAN, SL, LESNOVSKAYA, A, ESTEBAN-CORNEJO, I, et al. Aerobic Exercise, Cardiorespiratory Fitness, and the Human Hippocampus. Hippocampus 2021; 31(8): 817–44. Doi: 10.1002/hipo.23337.
ALGHAMDI, BS. The neuroprotective role of melatonin in neurological disorders. J Neuro Res. 2018; 96(7): 1136-1149. Doi: 10.1002/jnr.24220.
ANNWEILER, C, BRUGG, B, PEYRIN, JM, BARTHA, R, BEAUCHET, O. Combination of memantine and vitamin D prevents axon degeneration induced by amyloid-beta and glutamate. Neurobiol. Aging 2014; 35(2): 331–5. Doi: 10.1016/j.neurobiolaging.2013.07.029.
ANNWEILER, C. Vitamin D in dementia prevention. Ann. N. Y. Acad. Sci. 2016; 1367(1):57-63. Doi: 10.1111/nyas.13058.
BALION, C, GRIFFITH, LE, STRIFLER, L, et al. Vitamin D, cognition, and dementia: a systematic review and meta- analysis. Neurology 2012; 79(13): 1397–405. Doi: 10.1212/WNL.0b013e31826c197f.
BANERJEE, A, KHEMKA, VK, GANGULY, A, et al. Vitamin D and Alzheimer’s Disease: Neurocognition to Therapeutics. International Journal of Alzheimer’s Disease 2015; 192747. Doi: 10.1155/2015/192747.
BECK JD, KOCH, GG, ROZIER, RG, TUDOR, GE. Prevalence and risk indicators for periodontal attachment loss in a population of older community-dwelling blacks and whites. J Periodontol. 1990; 61(8): 521–8. Doi: 10.1902/jop.1990.61.8.521.
BORGES, CR, POYARES, D, PIOVEZAN, R, Nitrini, R, Brucki, S. Alzheimer’s disease and sleep disturbances: a review. Arq. Neuropsiquiatr. 2019; 77(11): 815-24. Doi: 10.1590/0004-282X20190149.
BREDESEN, DE. The end of Alzheimer’s: the first program to prevent and reverse cognitive decline. Nova York: Avery, 2017.
BROWN, J, BIANCO, JL, MCGRATH, JJ, EYLES, DW. 1,25- Dihydroxyvitamin D3 induces nerve growth factor, promotes neurite outgrowth and inhibits mitosis in embryonic rat hippocampal neurons. Neuroscience Letters 2003; 343(2): 139–43. Doi: 10.1016/S0304-3940(03)00303-3.
BUCHMAN, AS, BOYLE, PA, YU, L, et al. Total daily physical activity and the risk of AD and cognitive decline in older adults. Neurology 2012; 78(17): 1323–9. Doi: 10.1212/WNL.0b013e3182535d35.
CALVANI, R, PICCA, A, MONACO, MRL, et al. Of microbes and minds: a narrative review on the second brain aging. Front Med. 2018; 5: 53. Doi: 10.3389/fmed.2018.00053.
CANÁRIO, N, JORGE, L, MARTINS, R, SANTANA, I, CASTELO-BRANCO, M. Dual PET-fMRI reveals a link between neuroinflammation, amyloid binding and compensatory task-related brain activity in Alzheimer’s disease. Commun. Biol. 2022; 10;5(1): 804. Doi: 10.1038/s42003-022-03761-7.
CARUANA, M, CAUCHI, R, VASSALLO, N. Putative role of red wine polyphenols against brain pathology in Alzheimer’s and Parkinson’s disease. Front Nutr. 2016; 3:31. Doi: 10.3389/fnut.2016.00031.
CAVALCANTI, JLS, ENGERLHARDT, E. Aspectos da fisiopatologia da doença de Alzheimer esporádica. Rev. Bras. Neurol. 2012; 48(4): 21-9.
CHARIER, D, BEAUCHET, O, BELL, M, et al. Memantine plus vitamin D prevents axonal degeneration caused by lysed blood. ACS Chem. Neurosci. 2015; 6(3): 393–7. Doi: 10.1021/cn500303k.
CHOI, S, KIM, K, CHANG, J, et al. Association of Chronic Periodontitis on Alzheimer’s Disease or Vascular Dementia. J Am Geriatr Soc. 2019; 67(6):1234-9. Doi: 10.1111/jgs.15828.
CHOI, SH, BYLYKBASHI, E, CHATILA, ZK, et al. Combined adult neurogenesis and BDNF mimic exercise effects on cognition in an Alzheimer’s mouse model. Science 2018; 361 (6406), eaan8821. Doi: 10.1126/science.aan8821.
CUNNANE, S, NUGGENT, S, ROY, M, et al. Brain fuel metabolism, aging, and Alzheimer’s disease. Nutrition 2011; 27(1): 3-20. Doi: 10.1016/j.nut.2010.07.021.
DAVID, AVA, ARULMOLI, R, Parasuraman, S. Overviews of Biological Importance of Quercetin: A Bioactive Flavonoid. Pharmacogn Rev. 2016; 10(20): 84-9. Doi: 10.4103/0973-7847.194044.
DE MELO, SC, CHAMPS, APS, GOULART, RF, MALTA, DC, PASSOS, VMA. Dementias in Brazil: increasing burden in the 2000–2016 period. Estimates from the Global Burden of Disease Study 2016. Arq. Neuro-Psiquiatr. 2020; 78(12): 762-71. Doi: 10.1590/0004-282X20200059.
DELACOURTE, A. Maladie d’Alzheimer et démences. De la physiopathologie au traitement de la maladie d’Alzheimer. Rev Neurol (Paris) 2006; 162(10): 909-12. Doi: 10.1016/S0035-3787(06)75099-8.
DÉRY N, PILGRIM, M, GIBALA, M, et al. Adult hippocampal neurogenesis reduces memory interference in humans: Opposing effects of aerobic exercise and depression. Front Neurosci 2013; 7:66. Doi: 10.3389/fnins.2013.00066.
DOMINY, SS, LYNCH, C, ERMINI, F, et al. Porphyromonas gingivalis in Alzheimer’s disease brains: Evidence for disease causation and treatment with small molecule inhibitors. Science Advances 2019; 5(1): eaau3333. Doi: 10.1126/sciadv.aau3333.
ENGELHART MJ, GEERLINGS, MI, RUITENBERG, A, et al. Dietary intake of antioxidants and risk of Alzheimer disease. JAMA 2002; 287(24):3223-9. Doi: 10.1001/jama.287.24.3223
ERICKSON, KI, VOSS, MW, PRAKASH, S, et al. Exercise training increases size of hippocampus and improves memory. PNAS: 2011; 108(7): 3017–22. Doi: 10.1073/pnas.1015950108.
FAVA, A, PIRRITANO, D, PLASTINO, M, et al. The Effect of Lipoic Acid Therapy on Cognitive Functioning in Patients with Alzheimer’s Disease. J Neurodegener Dis. 2013; 454253: 1-7. Doi: 10.1155/2013/454253.
FEART, C, HELMER, C, MERLE, B, et al. Associations of lower vitamin D concentrations with cognitive decline and long-term risk of dementia and Alzheimer’s disease in older adults. Alzheimer’s & Dementia 2017; 13(11): 1207-16. Doi: 10.1016/j.jalz.2017.03.003.
FRANCIS, N. The role of intermittent fasting in brain health. Alzheimer’s Dement 2020; 16: (suppl.10): e043930. Doi: 10.1002/alz.043930.
FRATIGLIONI L, LAUNER, L J, ANDERSEN, K, et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based-cohorts. Neurology. 2000; v. 54, 11 Suppl 5: S10-5.
FRAUTSCHY, SA, HU, W, KIM, P, et al. Phenolic anti-inflammatory antioxidant reversal of Aβ-induced cognitive deficits and neuropathology. Neurobiology of Aging 2001; 22(6): 993–1005. Doi: 10.1016/s0197-4580(01)00300-1.
GARCION, E, WION-BARBOT, N, MONTERO-MENEI, CN, BERGER, F, WION, D. New clues about vitamin D functions in the nervous system. TRENDS in Endocrinology & Metabolism 2002; 13(3): 100-5. Doi: 10.1016/s1043-2760(01)00547-1.
GONG, YH, HUA, N, ZANG, X, et al. Melatonin ameliorates A1-42-induced Alzheimer’s cognitive deficits in mouse model. J. Pharm. Pharmacol. 2018; 70(1): 70–80. Doi: 10.1111/jphp.12830.
GREEN, R, ALLEN, LH, BJORKE-MONSEN, AL, et al. Vitamin B12 deficiency. Nat Rev Dis Primers 2017; 3: 17040. Doi: 10.1038/nrdp.2017.40.
GREEN, R, MILLER, JW. Vitamin B12 deficiency is the dominant nutritional cause of hyperhomocysteinemia in a folic acid-fortified population. Clin Chem Lab Med. 2005; 43(10):1048–51. Doi: 10.1515/CCLM.2005.183.
HADITSCH, U, ROTH, T, RODRIGUEZ, L, et al. Alzheimer’s disease-like neurodegeneration in Porphyromonas gingivalis infected neuron with persistent expression of active gingipains. J Alzheimer’s Dis. 2020; 75(4): 1361-76. Doi: 10.3233/JAD-200393.
HAGER, K, MARAHRENS, A, KENKLIES, M, RIEDERER, P, MÜNCH, G. Alpha-lipoic acid as a new treatment option for azheimer type dementia. Arch. Gerontol. Geriatr. 2001; 32(3): 275–82. Doi: 10.1016/S0167-4943(01)00104-2.
HARACH, T, MARUNGRUANG, N, DUTHIEUL, N, et al. Reduction of Abeta amyloid pathology in APPPS1 transgenic mice in the absence of gut microbiota. Scientific Reports 2017; 7: 41802. Doi: 10.1038/srep41802.
HE, Y, LI, B, SUN, D, CHEN, S. Gut Microbiota: Implications in Alzheimer’s Disease. J Clin Med 2020; 9(7): 2042. Doi: 10.3390/jcm9072042.
HENEKA, MT, CARSON, MJ, KHOURY, JE, et al. Neuroinflammation in Alzheimer's Disease. Lancet Neurol. 2015; 14(4): 388–405. Doi: 10.1016/S1474-4422(15)70016-5.
IBI, M, Sawada, H, Nakanishi, M, et al. Protective effects of 1alfa,25-(OH)2 D3 against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture. Neuropharmacology 2001; 40(6): 761–71. Doi: 10.1016/s0028-3908(01)00009-0.
ILIEVSKI, V, ZUCHOWSKA, PK, GREEN, SJ, et al. Chronic oral application of a periodontal pathogen results in brain inflammation, neurodegeneration and amyloid beta production in wild type mice. PLoS ONE 2018; 13(10): e0204941. Doi: 10.1371/journal.pone.0204941.
ISLAM, MR, VALARIS, S, YOUNG, MF, et al. Exercise hormone irisin is a critical regulator of cognitive function. Nature 2021; 3: 1058–70. Doi: 10.1038/s42255-021-00438-z.
JACK JR, CR, WISTE, HJ, VEMURI, P, et al. Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer’s disease. Brain 2010; 133(11):3336–48. Doi: 10.1093/brain/awq277.
JEDRYCHOWSKI, MP, WRANN, CD, PAULO, JA, et al. Detection and quantitation of circulating human irisin by tandem mass spectrometry. Cell Metab. 2015; 22(4): 734–40. Doi: 10.1016/j.cmet.2015.08.001.
JU, Y.S., LUCEY, B.P., HOLTZMAN, D.M. Sleep and Alzheimer disease pathology - a bidirectional relationship. Nat. Rev. Neurol. 2014; 10(2): 115-9. Doi: 10.1038/nrneurol.2013.269.
JUNGBAUER, G, STÄHLI, A, ZHU, X, et al. Periodontal microorganisms and Alzheimer disease - A causative relationship? Periodontology 2000. 2022; 89(1):59-82. Doi: 10.1111/prd.12429.
KAUR, D, BEHL, T, SEHGAL, A, et al. Decrypting the potential role of α-lipoic acid in Alzheimer's disease. Life Sciences 2021; 284: 119899. Doi: 10.1016/j.lfs.2021.119899.
KHAN, H, ULLAH, H, ASCHNER, M, CHEANG, WS, AKKOL, EK. Neuroprotective effects of quercetin in Alzheimer’s Disease. Biomolecules 2020; 10(1): 59. Doi: 10.3390/biom10010059.
KHAN, MTH, ORHAN, I, SENOL, FS, et al. Cholinesterase inhibitory activities of some flavonoid derivatives and chosen xanthone and their molecular docking studies. Chem. Biol. Interact. 2009; 181(3): 383–9. Doi: 10.1016/j.cbi.2009.06.024.
KIM, OY, SONG, J. The Role of Irisin in Alzheimer’s Disease. J. Clin. Med. 2018; 7: 407. Doi: 10.3390/jcm7110407.
KINNEY, JW, BEMILLER, SM, MURTISHAW, AS, et al. Inflammation as a central mechanism in Alzheimer’s disease. Alzheimer’s & Dementia: Translational Research & Clinical Interventions 2018; 4: 575-90. Doi: 10.1016/j.trci.2018.06.014.
KOU, J, WANG, M, SHI, J, et al. Curcumin Reduces Cognitive Deficits by Inhibiting Neuroinflammation through the Endoplasmic Reticulum Stress Pathway in Apolipoprotein E4 Transgenic Mice. ACS Omega 2021; 6(10), 6654−62. Doi: 10.1021/acsomega.0c04810.
KOWALSKI, K, MULAK, A. Brain-Gut-Microbiota Axis in Alzheimer’s Disease. J. Neurogastroenterol. Motil. 2019; 25: 48–60. Doi: 10.5056/jnm18087.
LEE, P, LINDERMAN, JD, SMITH, S, et al. Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell Metab. 2014; 19(2): 302–9. Doi: 10.1016/j.cmet.2013.12.017.
LIN, L, ZHENG, LJ, ZHANG, LJ. Neuroinflammation, Gut Microbiome, and Alzheimer’s Disease Mol Neurobiol. 2018; 55: 8243–50. Doi: 10.1007/s12035-018-0983-2.
LOURENCO, MV, FROZZA, RL, FREITAS, GB, et al. Exercise-linked FNDC5/irisin rescues synaptic plasticity and memory defects in Alzheimer’s models. Nature Medicine 2019; 25: 165-75. Doi: 10.1038/s41591-018-0275-4.
MANDER, BA, WINER, JR, JAGUST, WJ, WALKER, MP. Sleep: A Novel Mechanistic Pathway, Biomarker, and Treatment Target in the Pathology of Alzheimer's Disease? Trends in Neuroscience 2016; 39(8): 552-6. Doi: 10.1016/j.tins.2016.05.002.
MATTSON, MP, LONGO, VD, HARVIE, M. Impact of intermittent fasting on health and disease processes. Ageing Research Reviews 2017; 39: 46-58. Doi: 10.1016/j.arr.2016.10.005.
MCCADDON, A. Vitamin B12 in neurology and ageing; Clinical and genetic aspects. Biochimie 2013; 95(5): 1066-76. Doi: 10.1016/j.biochi.2012.11.017.
MIHARDJA, M, ROY, J, WONG, KY, et al. Therapeutic potential of neurogenesis and melatonin regulation in Alzheimer’s disease. Ann N Y Acad Sci. 2020; 1478(1) 43-62. Doi: 10.1111/nyas.14436.
MILLER, JW, HARVEY, DJ, BECKETT, LA, et al. Vitamin D status and rates of cognitive decline in a multiethnic cohort of older adults. JAMA Neurol. 2015; 72(11): 1295–303. Doi: 10.1001/jamaneurol.2015.2115.
MINTER, MR, ZHANG, C, LEONE, V, et al. Antibiotic-induced perturbations in gut microbial diversity influences neuro-inflammation and amyloidosis in a murine model of Alzheimer’s disease. Scientific Reports 2016; 6: 30028. Doi: 10.1038/srep30028.
MOLZ, P, SCHRÖDER, N. Potential Therapeutic Effects of Lipoic Acid on Memory Deficits Related to Aging and Neurodegeneration. Front Pharmacol. 2017; 8:849. Doi: 10.3389/fphar.2017.00849.
MORAN, M, LYNCH, CA, WALSH, C, et al. Sleep disturbance in mild to moderate Alzheimer’s disease. Sleep Medicine 2005; 6: 347–52. Doi: 10.1016/j.sleep.2004.12.005.
NEWPORT, M.T. Alzheimer: e se houver uma cura? A história das cetonas e do óleo de côco. Belo Horizonte.MG: ed Lazlo, 2019.
NISSOU, MF, GUTTIN, A, ZENGA, C, et al. Additional clues for a protective role of vitamin D in neurodegener- ative diseases: 1,25-dihydroxyvitamin D3 triggers an anti- inflammatory response in brain pericyte. J. Alzheimers Dis. 2014; 42(3): 789–99. Doi: 10.3233/JAD-140411.
NOBLE, JM, SCARMEAS, N, PAPAPANOU, PN. Poor Oral Health as a Chronic, Potentially Modifiable Dementia Risk Factor: Review of the Literature. Curr Neurol Neurosci Rep 2013; 13(10): 384. Doi: 10.1007/s11910-013-0384-x.
PELLEGRINI, C, ANTONIOLI, L, COLUCCI, R, BLANDIZZI, C, FORNAI, M. Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: A common path to neurodegenerative diseases? Acta Neuropathol. 2018; 136(3), 345–61. Doi: 10.1007/s00401-018-1856-5.
PETERSEN, PE, YAMAMOTO, T. Improving the oral health of older people: the approach of the WHO Global Oral Health Programme. Community Dent Oral Epidemiol. 2005; 33:81–92. Doi: 10.1111/j.1600-0528.2004.00219.x.
PISTOLLATO, F, CANO, SS, ELIO, I, et al. Role of gut microbiota and nutrients in amyloid formation and pathogenesis of Alzheimer disease. Nutr Ver. 2016; Vol. 74(10):624–34. Doi: 10.1093/nutrit/nuw023.
RAZ, N, LINDENBERGER, U, RODRIGUE, KM, et al. Regional brain changes in aging healthy adults: General trends, individual differences and modifiers. Cereb Cortex 2005; 15(11):1676–89. Doi: 10.1093/cercor/bhi044.
ROY, J, TSUI, KC, NG, J, FUNG, ML, LIM, LW. Regulation of melatonin and neurotransmission in Alzheimer’s Disease. Int J Mol Sci. 2021; 22(13): 6841. Doi: 10.3390/ijms22136841.
SABIA, S, FAYOSSE, A, DUMURGIER, J, et al. Association of sleep duration in middle and old age with incidence of dementia. Nature Communications 2021; 12(1): 2289. Doi: 10.1038/s41467-021-22354-2.
SABOGAL-GUÁQUETA, AM, MUÑOZ-MANCO, JI, RAMÍRES-PINEDA, JR, et al. The flavonoid quercetin ameliorates Alzheimer’s disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer’s disease model mice. Neuropharmacology 2015; 93, 134–45. Doi: 10.1016/j.neuropharm.2015.01.027.
SEIFAR, F, KHALILI, M, KHALEDYAN, H, et al. α-lipoic acid, functional fatty acid, as a novel therapeutic alternative for central nervous system diseases: a review. Nutr. Neurosci. 2019; 22 (5): 306–16. Doi: 10.1080/1028415X.2017.1386755.
SERENIKI, A, VITAL, MAB. A doença de Alzheimer: aspectos fisiopatológicos e farmacológicos. Rev. Psiquiat. RS 2008; 30: 1 Supl.
SHEHZAD, A, QURESHI, M, ANWAR, MN, LEE, YS. Multifunctional Curcumin Mediate Multitherapeutic Effects. J Food Sci 2017; 82(9): 2006-15. Doi: 10.1111/1750-3841.13793.
SHIMMYO, Y, KIHARA, T, AKAIKE, A, NIIDOME, T, SUGIMOTO, H. Flavonols and flavones as BACE-1 inhibitors: Structure–activity relationship in cell-free, cell-based and in silico studies reveal novel pharmacophore features. Biochim Biophys Acta 2008; 1780: 819–25. Doi: 10.1016/j.bbagen.2008.01.017.
SHUKLA, M, GOVITRAPONG, P, BOONTEM, P, REITER, RJ, SATAYAVIVAD, J. Mechanisms of Melatonin in Alleviating Alzheimer’s Disease. Current Neuropharmacology 2017; 15(7): 1010-31. Doi: 10.2174/1570159X15666170313123454.
SHYTLE, RD, BICKFORD, PC, REZAI-ZADEH, K, et al. Optimized Turmeric Extracts have Potent Anti-Amyloidogenic Effects. Current Alzheimer Research 2009; 6(6): 564–71. Doi: 10.2174/156720509790147115.
SMITH, A.D. Homocysteine-Lowering by B Vitamins Slows the Rate of Accelerated Brain Atrophy in Mild Cognitive Impairment: A Randomized Controlled Trial. PLoS ONE 2010; 5 (9):12244. Doi: 10.1371/journal.pone.0012244.
TAO, J, LUI, J, CHEN, X, et al. Mind-body exercise improves cognitive function and modulates the function and structure of the hippocampus and anterior cingulate cortex in patients with mild cognitive impairment. NeuroImage Clin. 2019; 23: 101834. Doi: 10.1016/j.nicl.2019.101834.
TEIXEIRA, J, SOUZA JUNIOR, PRB, HIGA, J, THEME FILHA, MM. Doença de Alzheimer: estudo da mortalidade no Brasil, 2000-2009. Cad. Saúde Pública 2015; 31(4): 1-12. Doi: 10.1590/0102-311X00144713.
ULLAH, H; KHAN, H. Anti-Parkinson potential of silymarin: Mechanistic insight and therapeutic standing. Front Pharmacol. 2018; 9: 422. Doi: 10.3389/fphar.2018.00422.
VASCONCELOS, AR, KINOSHITA, PF, YSHII, LM, et al. Effects of intermittent fasting on age-related changes on Na,K-ATPase activity and oxidative status induced by lipopolysaccharide in rat hippocampus. Neurobiol Aging 2015; 36(5): 1914–23. Doi: 10.1016/j.neurobiolaging.2015.02.020.
VILLAFLORES, OB, CHEN, YJ, CHEN, CP, YEH, JM, WU, TY. Effects of curcumin and demethoxycurcumin on amyloid-β precursor and tau proteins through the internal ribosome entry sites: A potential therapeutic for Alzheimer’s disease. Taiwanese Journal of Obstetrics and Gynecology 2012; 51(4): 554–64. Doi: 10.1016/j.tjog.2012.09.010.
VOGT, NM, KERBY, RL, Dill-MacFarland, KA, et al. Gut microbiome alterations in Alzheimer’s disease. Scientific Reports 2017; 7: 13537. Doi: 10.1038/s41598-017-13601-y.
WANG, DM, LI, SQ, WU, WL, et al. Effects of long-term treatment with quercetin on cognition and mitochondrial function in a mouse model of Alzheimer’s disease. Neurochem. Res. 2014; 39(8): 1533–43. Doi: 10.1007/s11064-014-1343-x.
WANG, X, SUN, G, FENG, T, et al. Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer’s disease progression. Cell Research. 2019; 29:787–803. Doi: 10.1038/s41422-019-0216-x.
WINER, JR, MANDER, BA, KUMAR, S, et al. Sleep Disturbance Forecasts b-Amyloid Accumulation across Subsequent Years. Current Biology 2020; 30(21), 4291–8. Doi: 10.1016/j.cub.2020.08.017.
WRANN, CD, WHITE, JP, Salogiannnis, J, et al. Exercise induces hippocampal BDNF through a PGC-1α/FNDC5 pathway. Cell Metab. 2013; 18(5): 649–59. Doi: 10.1016/j.cmet.2013.09.008.
XIE, L, KANG, H, XU, Q, et al. Sleep Drives Metabolite Clearance from the Adult Brain. Science 2013; 342: 373-7. Doi: 10.1126/science.1241224.
YAU SY, LAU, BWM, TONG, JB, et al. Hippocampal neurogenesis and dendritic plasticity support running-improved spatial learning and depression-like behaviour in stressed rats. PLoS One 2011; 6(9):e24263. Doi: 10.1371/journal.pone.0024263.
YOUDIM KA, SPENCER, JPE, SCHROETER, H, RICE-EVANS, C. Dietary flavonoids as potential neuroprotectants. Biol Chem. 2002; 383:503–19. Doi: 10.1515/BC.2002.052.
YU, W, WU, J, CAI, F, et al. Curcumin alleviates diabetic cardiomyopathy in experimental diabetic rats. PLoS ONE 2012; [s. l.], 7(12), e52013. Doi: 10.1371/journal.pone.0052013.
ZHANG, C, BROWNE, A, CHILD, D, TANZI, RE. Curcumin decreases amyloid-beta peptide levels by attenuating the maturation of amyloid-beta precursor protein. J Biol Chem 2010; 285(37): 28472–80. Doi: 10.1074/jbc.M110.133520.
ZHANG, L, XING, GQ, CHANG, BY, et al. α-lipoic acid protects rat cortical neurons against cell death induced by amyloid and hydrogen peroxide through the Akt signalling pathway. Neuroscience Letters 2001; 312(3): 125–8. Doi: 10.1016/s0304-3940(01)02205-4.
